Abstract
Opioid use affects up to 30% of pregnancies in Northwestern Ontario. Health care providers in Northwestern Ontario have varying comfort levels providing care to substance-involved pregnant women. Furthermore, health care practitioners, social service agencies and community groups in Northwestern Ontario often work in isolation with little multidisciplinary communication and collaboration. This article describes two workshops that brought together health and social service providers, community organizations, as well as academic institutions and professional organizations involved in the care of substance-involved pregnant and parenting women. The initial workshop presented best practices and local experience in the management of opioid dependence in pregnancy while the second workshop asked participants to apply a local Indigenous worldview to the implementation of clinical, research and program priorities that were identified in the first workshop. Consensus statements developed by workshop participants identified improved transitions in care, facilitated access to buprenorphine treatment, stable funding models for addiction programs and a focus on Indigenous-led programming. Participants identified a critical need for a national strategy to address the effects of opioid use in pregnancy from a culturally safe, trauma-informed perspective that takes into account the health and well-being of the woman, her infant, her family and her community.
Résumé
La consommation d’opioïdes affecte jusqu’à 30 % des grossesses dans le Nord-Ouest de l’Ontario. Le personnel soignant du Nord-Ouest ontarien est plus ou moins à l’aise d’offrir des soins aux femmes enceintes qui consomment des substances. De plus, les professionnels de la santé, les services sociaux et les groupes communautaires du Nord-Ouest de l’Ontario travaillent souvent isolément et ont peu de communications et de liens de collaboration multidisciplinaires. Notre article décrit deux ateliers qui ont rassemblé des dispensateurs de services sociaux et de santé, des organismes communautaires, des établissements d’enseignement et des associations professionnelles intervenant dans les soins aux femmes enceintes et aux mères qui consomment des substances. Le premier atelier a présenté des pratiques exemplaires et l’expérience locale de prise en charge de la dépendance aux opioïdes durant la grossesse; dans le second, les participants ont appliqué une vision du monde autochtone locale à la mise en œuvre des priorités (cliniques, de recherche et de programme) définies durant le premier atelier. Les déclarations de consensus élaborées par les participants ont mentionné l’amélioration des transitions dans les soins, la facilitation de l’accès au traitement à la buprenorphine, des modèles de financement stables pour les programmes de lutte contre les toxicomanies et un accent sur les programmes dirigés par les Autochtones. Les participants ont défini le besoin urgent d’une stratégie nationale pour aborder les effets de la consommation d’opioïdes pendant la grossesse selon une perspective culturellement sûre et sensible aux traumatismes, qui tienne compte de la santé et du bien-être de la femme, de son nourrisson, de sa famille et de sa communauté.
Similar content being viewed by others
References
Truth and Reconciliation Commission of Canada. Honouring the Truth, Reconciling for the Future: Summary of the Final Report of the Truth and Reconciliation Commission of Canada. Ottawa, ON: Truth and Reconciliation Commission of Canada, 2015; 145.
Nishnawbe Aski Nation. Nishnawbe Aski Nation — Sectors. Nanonca, 2016. Available at: http://www.nan.on.ca/article/sectors-5.asp (Accessed November 2, 2015).
Uddin F. Hope in Fort Hope: First Nations community is winning the battle against prescription drug abuse. Can Fam Physician 2013;59:391–93. PMID: 23585610.
Ministry of Health and Long-Term Care. Integrated Health Service Plan 2013–2016. Toronto, ON: Ministry of Health and Long-Term Care, 2012; 54–57.
Stasiuk T. BORN Database for the Lake of the Woods Hospital. Ottawa, ON: BORN Ontario, 2014.
Kelly L, Dooley J, Cromarty H, Minty B, Morgan A, Madden S, et al. Narcotic-exposed neonates in a First Nations population in northwestern Ontario: Incidence and implications. Can Fam Physician 2011;57:e441–47. PMID: 22084474.
Dooley R, Dooley J, Antone I, Guilfoyle J, Gerber-Finn L, Kakekagumick K, et al. Narcotic tapering in pregnancy using long-acting morphine: An 18-month prospective cohort study in Northwestern Ontario. Can Fam Physician 2015;61:e88–95. PMID: 25821873.
Kelly L, Guilfoyle J, Dooley J, Antone I, Gerber-Finn L, Dooley R, et al. Incidence of narcotic abuse during pregnancy in northwestern Ontario: Three-year prospective cohort study. Can Fam Physician 2014;60:e493–98. PMID: 25316764.
Jumah NA, Edwards C, Loewen L, Dooley J, Gerber-Finn L, Kelly L. Observational study of the safety of buprenorphine + naloxone in pregnancy in a rural and remote population. BMJ Open 2016;6:e011774. PMID: 27799240. doi: 10.1136/bm]open-2016-011774.
Persichino N. BORN Database for the Thunder Bay Regional Health Sciences Centre. Ottawa, ON: BORN Ontario, 2014.
World Health Organization. Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy. Geneva, Switzerland: WHO, 2014; 14.
Wong S, Ordean A, Kahan M. Substance use in pregnancy. J Obstet Gynaecol Can 2011;33:367–84. PMID: 21501542. doi: 10.1016/S1701-2163(16)34855-1.
Daily Med. Naloxone Hydrochloride (Product Monograph). Bethesda, MD: National Institutes of Health, 2013. Available at: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d524c0e5-a7c2-40b2-9eed-2caf71c787dc (Accessed August 23, 2013).
Debelak K, Morrone WR, O’Grady KE, Jones HE. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy — Initial patient care and outcome data. Am J Addict 2013;22:252–54. PMID: 23617867. doi: 10.1111/j.1521-0391.2012.12005.X.
Lund IO, Fisher G, Welle-Strand G, O’Grady KE, Debelak K, Morrone WR, et al. A comparison of buprenorphine + naloxone to buprenorphine and methadone in the treatment of opioid dependence during pregnancy: Maternal and neonatal outcomes. Subst Abuse 2013;7:61–74. PMID: 23531704. doi: 10.4137/SART.S10955.
Wiegand SL, Stringer EM, Stuebe AM, Jones H, Seashore C, Thorp J. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol 2015;125:363–68. PMID: 25569005. doi: 10.1097/AOG.0000000000000640.
Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010;363:2320–31. PMID: 21142534. doi: 10.1056/NEJMoa1005359.
Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: Assessment and management. Addict Dis 1975;2(1-2):141–58. PMID: 1163358.
Kelly L, Antone I, St. Pierre-Hansen N. Aboriginal Maternity Care Resourcebook. Sioux Lookout, ON: Sioux Lookout Meno Ya Win Health Centre, 2012.
Dooley J, Gerber-Finn L, Antone I, Guilfoyle J, Blakelock B, Balfour-Boehm J, et al. Buprenorphine/naloxone use in pregnancy for treatment of opioid dependence: A prospective cohort study of 30 patients. Can Fam Physician 2016;62(4):e194–200.
Fernandez S, Bruni T, Bishop L, Turuba R, Olibris B, Jumah NA. Differences in hospital length of stay between neonates exposed to buprenorphine versus methadone in utero. 94th Annual Conference of the Canadian Paediatric Society, Abstract 61, May 31, 2017.
Jumah NA. Rural, pregnant, and opioid dependent: A systematic review. Subst Abuse 2016;10(Suppl 1):35–41. PMID: 27375357. doi: 10.4137/SART.S34547.
Kashak D, for the Thunder Bay Drug Strategy: Maternal Substance Use & Child Working Group. An Overview of Issues, Impacts and Services for Women who are Using Substances and are Pregnant or Parenting within the City of Thunder Bay: Literature Review & Environmental Scan of Programs in Thunder Bay. Thunder Bay, ON: City of Thunder Bay, 2015.
Bishop L, Olibris B, Kahan M, Jumah NA. Substance use in pregnancy and parenting: An environmental scan of services in Northwestern Ontario. ICEMEN 2016, Sault Ste. Marie, ON, June 24, 2016.
Shibogama Health Authority. Maternal Addictions Continuum of Care Project Summary. Sioux Lookout, ON: Shibogama First Nations Council, January 23, 2013.
Ministry of Health and Long-Term Care. News Release: Ontario Improving Access to Aboriginal Midwifery Care, February 9, 2017. Available at: https://news.ontario.ca/mohltc/en/2017/02/ontario-improving-access-to-aboriginal-midwifery-care.html?utm_source=ondemand&utm_medium= email&utm_campaign=m (Accessed March 7, 2017).
Bernosky D. Proposal Health Care Foundations: Pre-Natal & Infant Care Program. Thunder Bay, ON: Confederation College Regional Workforce Development, November 2014.
Renk K, Boris NW, Kolomeyer E, Lowell A, Puff J, Cunningham A, et al. The state of evidence-based parenting interventions for parents who are substance-involved. Pediatr Res 2016;79:177–83. PMID: 26484624. doi: 10.1038/pr.2015.201.
Graves LE, Turner S, Nader M, Sinha S. Breastfeeding and opiate substitution therapy: Starting to understand infant feeding choices. Subst Abuse 2016;10(Suppl 1):43–47. PMID: 27429549. doi: 10.4137/SART.S34553.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding: The Thunder Bay Regional Health Research Institute and the Sioux Lookout Meno Ya Win Health Centre supported the initial workshop. The second workshop was supported by the Canadian Institutes of Health Research and the Centre for Rural and Northern Health Research at Lakehead University.
Conflict of Interest: None to declare.
Rights and permissions
About this article
Cite this article
Jumah, N.A., Bishop, L., Franklyn, M. et al. Opioid use in pregnancy and parenting: An Indigenous-based, collaborative framework for Northwestern Ontario. Can J Public Health 108, e616–e620 (2017). https://doi.org/10.17269/CJPH.108.5524
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.17269/CJPH.108.5524